In this field, an important work was published by Boots et al. (10), who found that episodic memory and executive functions impairment were more pronounced in BDNF Met-carriers in a large cohort of 1,023 subjects at risk for Alzheimer's disease, with the effect size being modulated by the burden of beta amyloid plaques. The gene discussed is BDNF; the disease is Alzheimer disease.